BiomX To Present Data From Phase 1b/2a Study Of BX004 For Treatment Of Cystic Fibrosis Patients With Chronic Pulmonary Infections At 34th European Congress Of Clinical Microbiology And Infectious Diseases
Author: Benzinga Newsdesk | April 23, 2024 08:11am